Clinical Notes AI's AI-powered platform uses over 25 different AI models to generate highly complex behavioral healthcare ...

Unite.AI is committed to rigorous editorial standards. We may receive compensation when you click on links to products we review. Please view our affiliate disclosure. Technological innovation has ...

The company's CEO, James Dentzer, expressed optimism about the progress of Curis's clinical programs and the ... emavusertib. In terms of analyst ratings, H.C. Wainwright adjusted its outlook ...

While welcoming these positive changes, the CPT reiterates its recommendations to improve the screening for injuries at ...

The future of 23andMe, a genetic testing company, is uncertain due to financial challenges and recent workforce reductions.

Yaron Werber has given his Buy rating due to a combination of factors, primarily the promising progress and outcomes of IO Biotech’s clinical trials. The company’s Phase 3 melanoma study is on ...

Medical Properties Trust has made progress with liquidity but faces rising debt and asset write-downs. Learn why MPW stock ...

Q3 2024 Earnings Call Transcript November 13, 2024 Operator: Greetings, and welcome to the Tenon Medical Third Quarter 2024 ...

GE HealthCare's AI initiatives, including AI-powered imaging solutions and strategic partnerships, are led by its chief AI ...

Notes payable, plus accrued interest, totaled approximately $6.9 million. The current portion of the notes payable plus accrued interest totaled approximately $3.7 million. Included in the current ...

The company reported a strong cash position, which is expected to fund operations into late 2026, and emphasized the progress made in its clinical programs, including the completion of enrollment ...

Compared with a year ago, Silver Ring Value Partners' portfolio is more undervalued and better balanced. Click here to read ...